AVXL
Anavex Life Sciences Corp.
Company Overview
| Mkt Cap | $695.74M | Price | $7.97 |
| Volume | 1.35M | Change | -0.75% |
| P/E Ratio | -16.2 | Open | $8.05 |
| Revenue | -- | Prev Close | $8.03 |
| Net Income | $-43.0M | 52W Range | $6.62 - $14.44 |
| Div Yield | N/A | Target | $34.33 |
| Overall | 44 | Value | 40 |
| Quality | 47 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyAnavex Life Sciences Corp. (AVXL) is a leading Healthcare company in the Biotechnology industry, currently trading at $7.97 with a market capitalization of $695.74 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows AVXL with a volume of 1.35 million shares. The stock opened up 0.25% from yesterday's close of $8.03. Current analyst estimates project earnings of $-0.56 per share for this year, with next year targeting $-0.49.
AVXL demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including LGND, ABIO, PTN, CORT, BCRX.
Key investment considerations for AVXL include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 330.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVXL | $7.97 | -0.7% | 1.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Anavex Life Sciences Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW